AstraZeneca to acquire biotech firm at cost of up to $1B
AstraZeneca makes a deal to buy another biotech company, this one with a price tag that could reach $1 billion.
AstraZeneca to build $2.5B research hub in Beijing
AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
AstraZeneca Invests $2.5 Billion in R&D Center in China
The pharmaceutical company said the investment in the research-and-development center in Beijing will bolster its footprint ...
Fierce Biotech6d
AstraZeneca goes in vivo, penning $1B deal for Belgian off-the-shelf cell therapy biotech
AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its ...
AstraZeneca buys cell therapy firm EsoBiotec for $1bn
British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up ...
Yahoo Finance2d
AstraZeneca invests $2.5 billion in Beijing hub amid probe
(Bloomberg) — AstraZeneca Plc (AZN) will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was ...
BioPharma Dive6d
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...
British pharma giant AstraZeneca to invest $2.5 billion in new China hub
British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...